The latest government news focussing on the transition to a greener future, international immigration and global human rights laws, crime legislation, the UK housing landscape and the latest government policy.
Poorer health metrics, particularly for respiratory and chronic diseases, are strongly linked to a higher proportion of votes for Reform UK, a BMJ Group study suggests. This association surge in reform highlights the critical need for all policymakers to urgently address health inequalities.
Anthony van Hoffen, Real Estate Partner at Lewis Silkin LLP, provides us with a guide discussing what you need to check when making development site visits.
Dr Karen McAuliffe, PI on the European Research Council funded project ‘Law and Language at the European Court of Justice’, discusses the impact of language and multilingualism on the role of Advocate General at the Court of Justice of the European Union.
Megan Warrender, Writer, examines the work of Chris Skidmore MP, Minister of State for Universities, Science, Research and Innovation, in particular, his endeavours to boost University research funding in the UK.
As the Government presses ahead with an agenda to empower tenants, Martin Taylor, Deputy CEO of Content Guru, argues that AI is crucial to transforming social housing providers’ engagement with their customers.
Claire Foxall, Executive Vice President, Public Sector of Proxima reveals that when faced with peaks in demand, government is increasingly dealing with resource challenges by infusing flexible procurement capability.
Now that we seem to be entering the end game phase both in negotiations between the UK and the EU and in the dispute between the government and the majority of MPs, what should the foreign exchange market (forex) expect?
David Mann, Managing Director, dxw digital shares his expert thoughts on making bench contracts work, including the UK Government’s G-Cloud and Digital Outcomes and Specialists (DOS) frameworks.
The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.
Here, we discuss the freshly elected European Commissioners of the 2019-2024 period, including their duties and a vision of the EU their work attempts to shape.
